PCOS, Endometriosis, and Fertility: How Hormonal Disruption Connects Them

Reproductive disorders have long been treated as separate clinical categories: a fertility specialist handles PCOS, a gynecologist manages endometriosis, and an internist addresses metabolic disease. Yet the biology underlying these conditions overlaps in ways that matter enormously for how they are understood, diagnosed, and managed. Insulin resistance, chronic inflammation, cortisol dysregulation, and environmental toxin exposure appear across all of them, suggesting that the reproductive system functions less as an isolated organ system and more as a sensitive readout of whole-body health.

Created with AI

One of the clearest signals that reproductive medicine is evolving its conceptual framework came with a global consensus published in The Lancet, which Dr. Michael Diamonds highlighted in his clinical commentary. The condition long known as polycystic ovarian syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). The change followed input from 56 academic, clinical, and patient organizations and reflects a recognition that has been building for years: the ovaries are not the primary site of the problem. The disorder is a full-body hormonal-metabolic condition in which the ovaries are one of several affected organs.

According to Dr. Diamonds, three interconnected drivers explain the most visible manifestation of the condition, abdominal fat accumulation. Elevated androgens direct fat storage toward the abdomen rather than the hips and thighs. Insulin resistance, which he notes may be present in up to 70% of women with the condition, forces the pancreas to produce excess insulin, which in turn signals the ovaries to produce more testosterone. Chronic low-grade inflammation amplifies both processes. These three factors form a self-reinforcing loop: high insulin drives androgen excess, androgen excess worsens insulin resistance, and inflammation keeps both elevated.

The practical implication of this framework is that interventions targeting only one driver are unlikely to produce durable results. Dr. Diamonds describes a staged approach that addresses all three simultaneously: modifying carbohydrate quality and meal sequencing to reduce postprandial insulin spikes, adding resistance training to increase sex hormone-binding globulin (SHBG) which binds free testosterone before it can redirect fat storage, and addressing inflammation through omega-3 fatty acids and the removal of refined vegetable oils and ultraprocessed foods. He also notes that a randomized controlled trial found myo-inositol and D-chiro-inositol in a 40:1 ratio, which he describes as the ratio naturally maintained in healthy physiology, reduced free testosterone, fasting insulin, and insulin resistance compared to placebo. Sleep and cortisol management are treated in this framework not as lifestyle add-ons but as hormonal interventions, since elevated cortisol from poor or inconsistent sleep feeds the same testosterone-insulin loop.

Created with AI

Dr. Natalie Crawford, speaking with Dr. Mark Hyman, offers a reframe that extends beyond PCOS to reproductive health broadly. Infertility and irregular cycles, she argues, are often the first measurable sign that inflammation, insulin resistance, thyroid dysfunction, or environmental toxin exposure has reached a threshold that disrupts the communication axis between the brain and the ovaries. In this view, the reproductive system functions as a sensitive early warning system for overall cellular function, not merely as a fertility organ.

One of the mechanisms Crawford emphasizes is mitochondrial damage. Chronic inflammation, she explains, acts like interference on the hormonal signaling pathway between the hypothalamus and the ovary. It also directly damages mitochondria within eggs, a concern that extends beyond fertility because mitochondrial DNA is inherited exclusively from the mother. Inflammation in the follicular fluid has been associated with abnormally shaped mitochondria in eggs, according to Crawford.

Her clinical approach organizes the modifiable drivers of inflammatory burden into five categories: food, toxins, stress, sleep, and exercise. On sleep specifically, she notes that for every hour less of sleep a woman gets, she produces fewer eggs in an IVF cycle, and that for men, each hour of sleep lost correlates with lower testosterone and reduced sperm count. On metabolic markers, she describes fasting insulin as her preferred early signal, noting that she sees it elevated in the majority of patients who present as outwardly healthy.

The toxin category deserves particular attention because it involves distinctions that are not widely known. Crawford points out that fragrance-free and unscented are not the same label: unscented products can still contain phthalates used to mask odors. She identifies plastic cutting boards, Teflon cookware, thermal paper receipts, and to-go food containers as among the highest-exposure sources in a typical household. These are not dramatic or unusual exposures; they are routine, which is precisely why they accumulate.

Created with AI

If PCOS has suffered from a conceptual mislabeling, endometriosis has suffered from something arguably more damaging: a diagnostic delay averaging five to twelve years in most countries, according to Dr. Hanado, a reproductive medicine specialist who spoke with Peter Attia. He estimates the condition affects roughly 10% of reproductive-age women, making the scale of underdiagnosis a significant public health issue.

Endometriosis occurs when endometrial-like tissue grows outside the uterus, on the ovaries, bowel, bladder, and in some cases the diaphragm. A closely related condition, adenomyosis, involves similar tissue growing within the muscular wall of the uterus itself. Dr. Hanado suggests adenomyosis may affect 20 to 30% of women and is even more underdiagnosed than endometriosis. Notably, he notes that up to 70% of women with endometriosis also have adenomyosis, meaning the two conditions frequently coexist.

The pain of endometriosis, in Dr. Hanado's framework, operates on three distinct levels that require different treatments. Nociceptive pain arises from active lesions and responds to surgery and hormonal suppression. Neuropathic pain results from nerve infiltration by lesion tissue and may respond to medications such as gabapentin or SNRIs. The third type, nociplastic or central sensitization pain, occurs when the nervous system has been rewired by years of untreated pain; the brain and spinal cord have learned to amplify pain signals even after the original tissue source is addressed. Surgery cannot reverse central sensitization. This is why Dr. Hanado frames early diagnosis not merely as a quality-of-life issue but as a neurological one: every year of diagnostic delay increases the probability that pain has become self-sustaining.

Created with AI

A common concern for women with endometriosis is its effect on fertility, and Dr. Hanado's account is more nuanced than the general assumption that endometriosis uniformly impairs conception. The primary mechanism of impairment appears to be mechanical: adhesions from endometriosis can compromise fallopian tube function, reducing the likelihood of natural conception. Implantation itself, however, appears largely unaffected when good-quality embryos are transferred. Women with endometriosis may produce fewer eggs per IVF cycle, but the quality per egg is similar when matched for age, according to Dr. Hanado.

For adenomyosis specifically, he describes a protocol in which suppression with a GnRH agonist for two to four months before a frozen embryo transfer improves implantation rates and reduces miscarriage risk by approximately 30%. This is a meaningful clinical distinction because adenomyosis is frequently overlooked in fertility workups, and its treatment before embryo transfer may significantly change outcomes.

On diagnosis, Dr. Hanado argues that laparoscopy, long considered the gold standard, is no longer necessary as a first step. MRI and specialized transvaginal ultrasound with bowel preparation can achieve 95 to 98% sensitivity and specificity for endometriosis. The limiting factor is not the technology but the availability of radiologists trained in the specific protocol, which remains uneven across institutions and regions.

Created with AI

Running through the clinical accounts of PCOS, fertility disruption, and endometriosis is a common thread: the hormonal consequences of chronic stress. Cortisol, the primary stress hormone, amplifies insulin resistance, drives androgen overproduction, disrupts sleep architecture, and suppresses immune regulation. In the PCOS framework described by Dr. Diamonds, cortisol is not a secondary concern but a primary hormonal driver that must be addressed for other interventions to hold.

The connection between chronic stress and autoimmune disease adds another layer. The observation that approximately 82% of autoimmune cases occur in women has prompted examination of sex-specific stress physiology. Drawing on the work of Dr. Gabor Maté, one framework links unresolved trauma and chronic sympathetic nervous system activation to the conditions under which autoimmune disease develops. The loss of estrogen, which has anti-inflammatory properties, during perimenopause and menopause may help explain why autoimmune diagnoses appear to spike in women's 40s and 50s. This convergence of stress physiology, hormonal transition, and immune dysregulation suggests that the same systemic conditions that disrupt reproductive function earlier in life may continue to manifest in different forms as hormonal milestones shift.

The practical implication across all of these conditions is that stress management is not a soft or optional component of treatment. It is a direct hormonal intervention. Whether the mechanism is cortisol's amplification of insulin resistance in PCOS, its contribution to inflammatory burden in endometriosis, or its role in immune dysregulation, the biological pathways are specific and measurable.

Created with AI

• The renaming of PCOS to PMOS reflects clinical consensus that the condition is a systemic hormonal-metabolic disorder, not primarily an ovarian one, with insulin resistance, androgen excess, and chronic inflammation forming a self-reinforcing loop.
• According to Dr. Natalie Crawford, irregular cycles and infertility may be early signs of systemic dysfunction, including insulin resistance and mitochondrial damage from inflammation, rather than isolated reproductive problems.
• Dr. Hanado estimates the diagnostic delay for endometriosis averages five to twelve years, and that each year of delay increases the risk of central sensitization, a form of chronic pain that surgery cannot reverse.
• Adenomyosis, which may coexist with endometriosis in up to 70% of cases, can be addressed before IVF with GnRH agonist suppression, which Dr. Hanado associates with approximately 30% reduction in miscarriage risk.
• Non-invasive imaging with MRI and specialized ultrasound can achieve 95 to 98% diagnostic accuracy for endometriosis, according to Dr. Hanado, making surgical diagnosis no longer a necessary first step when trained radiologists are available.
• Cortisol dysregulation from chronic stress and poor sleep amplifies insulin resistance, androgen excess, and inflammatory burden across PCOS, fertility disruption, and autoimmune conditions, making stress physiology a central rather than peripheral concern in reproductive health.